FindTrial
Sign In

Prevalence of Sarcopenia in Type 2 Diabetes Mellitus Patients

Prevalence of Sarcopenia in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/106727
Enrollment
264
Registered
2026-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil

Sponsors

Rakshith G Maiya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals diagnosed with Type 2 Diabetes Mellitus for a duration of greater than or equal to 5 years and on regular medication

Exclusion criteria

Exclusion criteria: History of lower limb amputation. Active lower limb ulcer. Systemic illness, which hinders participation in the study like cancer, neurodegenerative diseases, etc.

Design outcomes

Primary

MeasureTime frame
Prevalence of sarcopenia in Type 2 Diabetes Mellitus Patients assessed using AWGS 2019 consensus will be reported in percentage.Timepoint: At baseline ( at time of recruitment )—

Secondary

MeasureTime frame
To explore the correlation between the use of different anti-diabetic medications & the prevalence of sarcopenia in T2DM patients. To evaluate the relationship between the duration of T2DM & the prevalence of sarcopenia.Timepoint: At baseline ( at time of recruitment )—

Countries

India

Contacts

Public ContactMrs Anupama Harihar

Kasturba Medical College, Manipal

mm.prabhu@manipal.edu9632118700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026